Veracyte, Inc. (VCYT)
NASDAQ: VCYT · IEX Real-Time Price · USD
21.26
-0.07 (-0.33%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Veracyte Market Cap
Veracyte has a market cap or net worth of $1.63 billion as of July 2, 2024. Its market cap has decreased by -12.40% in one year.
Market Cap
1.63B
Enterprise Value
1.43B
1-Year Change
-12.40%
Ranking
Category
Stock Price
$21.26
Market Cap Chart
Since October 30, 2013, Veracyte's market cap has increased from $274.10M to $1.63B, an increase of 492.95%. That is a compound annual growth rate of 18.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 1.63B | -19.11% |
| Dec 29, 2023 | 2.01B | 18.01% |
| Dec 30, 2022 | 1.70B | -41.83% |
| Dec 31, 2021 | 2.93B | 3.30% |
| Dec 31, 2020 | 2.83B | 107.80% |
| Dec 31, 2019 | 1.36B | 167.37% |
| Dec 31, 2018 | 510.00M | 129.42% |
| Dec 29, 2017 | 222.30M | 2.77% |
| Dec 30, 2016 | 216.30M | 8.58% |
| Dec 31, 2015 | 199.20M | -8.37% |
| Dec 31, 2014 | 217.40M | -28.72% |
| Dec 31, 2013 | 305.00M | 11.27% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evotec SE | 1.70B |
| Immunocore Holdings | 1.69B |
| Edgewise Therapeutics | 1.68B |
| National HealthCare | 1.67B |
| Teladoc Health | 1.66B |
| Keros Therapeutics | 1.65B |
| Galapagos NV | 1.63B |
| Akero Therapeutics | 1.62B |